BetterLife Pharma Inc.

CSE: BETR, OTCQB: BETRF, FRA: NPAU

Company Logo

Company Overview

BetterLife Pharma Inc. is an emerging biotechnology company engaged in the development and commercialization of next generation psychedelic products for the treatment of mental disorders. Utilizing drug delivery platform technologies, BetterLife is also refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus.

Financial Highlights

$0

Revenue (ttm)

-$22,808

Gross Profit (ttm)

-$0.11

Diluted EPS (ttm)

Management Team

Dr. Ahmad Doroudian Ph.D.
Founder, CEO & Chairman

Ms. Moira Ong C.A., CPA, CA, CFA
Chief Financial Officer

Dr. Hooshmand Sheshbaradaran Ph.D.
Chief Operating Officer

Mr. Scott Rudge Ph.D.
Head of CMC

Anthony Calandra Ph.D.
Head of Regulatory

Dr. Abdi Ghaffari Ph.D.
Head of Preclinical & Toxicology

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.

Company Profile

Website

Twitter

Presentation

Key Highlights

Market Capitalization
$0

Shares Outstanding
0

Shares Short (% of Float)
()

Insider Ownership
9%